Ludwig Institute for Cancer Research
51 clinical trials · Sponsor
◉ Watch Ludwig Institute for Cancer Research
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies (NCT02963831) | Ludwig Institute for Cancer Research | 2017-09-07 |
Track Ludwig Institute for Cancer Research automatically
Every clearance here is in the API, with alerts when new ones post.